Previous 10 | Next 10 |
MONTREAL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) is pleased to announce that, following a recent compilation of all historical drilling data on the Amanda project , the Company traced the presence o...
MONTREAL, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “the Company”) is pleased to announce the start of prospecting work on the Lithium SM project after several weeks of delays caused by forest fires. Covering 10,864 h...
MONTREAL, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “the Company”) is pleased to announce that an option agreement has been entered into between Vanstar Mining Resources Inc and the Company regarding the Amanda project. C...
MONTREAL, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “the Company”) announces that it has acquired from privately held Arlène Explorations Ltd eleven additional new mining cells in the immediate vicinity of the Abra...
MONTREAL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) is pleased to announce the start of prospecting work for critical minerals on the Lichen project after several weeks of delay caused by forest fires. Cove...
MONTREAL, July 25, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) acquired by map staking and from two prospectors the Abrat SM project consisting of 148 cells with an area of approximately 6,590 hectares loc...
Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch Molecure can proceed with clinical trial s in the U.S. A ...
Press release Molecure completes successful S econdary P ublic O ffering (SPO) of approximately PLN 50 million ( USD 12 million ) with proceeds to be used to fund and build a first in class, sustainable ...
OATD-01 is a first in class chitotriosidase 1 (CHIT1) inhibitor with disease modifying potential in sarcoidosis and other interstitial lung diseases Clearance of the IND application will pave the way for Molecure to initiate the study in the United States becoming only the second Polish b...
MONTREAL, June 07, 2023 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) announces that it has delayed all exploration activities at its James Bay lithium projects following an emergency fire evacuation order from the Ministry ...
News, Short Squeeze, Breakout and More Instantly...
Command Security Corporation Company Name:
MOC Stock Symbol:
NYSE Market:
Command Security Corporation Website:
Initiation of Phase II clinical trial of OATD-01 (KITE) for the treatment of pulmonary sarcoidosis following approval from the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). World's first administration of a chitotriosidase 1...
- OATD-01 is an innovative, first-in-class chitinase inhibitor for the treatment of sarcoidosis among other diseases where chronic inflammation leads to tissue remodeling and fibrosis - In the phase II clinical trial (KITE study), patients will take a daily oral dose of 25 mg OATD-01 or...
MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) announces part of the results of the work program consisting of eight drill holes for a total of 2,484 meters on the Gaboury project . Highlig...